SCHEMBL30097040

SCHEMBL30097040

CCCCOC(=O)N1CCn2ncc(C=O)c2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 2/20 0.41
▸ DRD4 P21917 2/20 0.41
▸ DRD3 P35462 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HRH2 P25021 4/20 0.38
▸ HRH1 P35367 4/20 0.38
▸ KMT2A Q03164 1/20 0.36
▸ CREBBP Q92793 1/20 0.35
▸ PLA2G2A P14555 2/20 0.35
▸ SMYD3 Q9H7B4 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ OPRD1 P41143 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ P2RY12 Q9H244 2/20 0.33
▸ GPR119 Q8TDV5 1/20 0.33
▸ BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30097002 0.81 LMNA (0.43) LMNAPOLBSMN1; SMN2HRH2HRH1
SCHEMBL31173444 0.78 MEN1 (0.46) SMN1; SMN2HRH2HRH1KMT2APTGDR2
SCHEMBL17925988 0.74 SMN1; SMN2 (0.45) LMNAPOLBSMN1; SMN2HRH2HRH1
SCHEMBL30297607 0.70 MAPT (0.43) LMNAPOLBSMN1; SMN2HRH2HRH1
SCHEMBL9627031 0.70 SMN1; SMN2 (0.50) LMNAPOLBSMN1; SMN2HRH2HRH1
SCHEMBL9405372 0.70 POLB (0.73) LMNAPOLBSMN1; SMN2HRH2HRH1
SCHEMBL7832611 0.69 GAA (0.54) LMNAPOLBSMN1; SMN2HRH2HRH1
SCHEMBL29742051 0.69 LMNA (0.43) LMNAPOLBSMN1; SMN2HRH2HRH1
SCHEMBL30376374 0.69 ABHD6 (0.41) LMNAPOLBSMN1; SMN2HRH2HRH1
SCHEMBL29742093 0.69 SMN1; SMN2 (0.40) LMNAPOLBSMN1; SMN2HRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4096667-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 — — EP disclosed
Send feedback